SOPHiA GENETICS SA
SOPHNasdaq
$5.87
↑ +0.7%Jul 17 close · end-of-day
Price
1Y↑ +62.2%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
No screener snapshot for this ticker.
Company profile
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Company was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
- CEO
- Jurgi Camblong
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 520
- Website
- sophiagenetics.com
Management & directors
- Menu PhilippeChief Medical Officer
- Xu ZhenyuChief Scientific Officer
- Camblong JurgiChief Executive Officer
- Cardoza GeorgeChief Financial Officer
- Muken RossChief Executive Officer
- Puylaert KevinChief Sales Officer
- Valente ManuelaChief People Officer
- Verma AbhimanyuChief Technology Officer
- Van Well DaanChief Legal Officer
Roles derived from SEC Form 4 filings.
Earnings
No reported earnings periods on file.
Financial statements
No annual data.
No quarterly data.
Company news
Jun 22, 2026
Jun 17, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-13 | Menu Philippe· Chief Medical Officer | Sale | 5,000 | $5.70 | $28,505.00 | filing |
| 2026-07-13 | Xu Zhenyu· Chief Scientific Officer | Sale | 4,000 | $5.70 | $22,819.20 | filing |
| 2026-07-10 | Camblong Jurgi· Executive Chairman | Sale | 8,500 | $5.62 | $47,791.25 | filing |
| 2026-07-07 | Camblong Jurgi· Executive Chairman | Sale | 17,685 | $5.28 | $93,327.28 | filing |
| 2026-07-06 | Camblong Jurgi· Executive Chairman | Sale | 22,486 | $5.26 | $118,163.93 | filing |
| 2026-07-06 | Muken Ross· Chief Executive Officer | Sale | 9,838 | $5.22 | $51,354.36 | filing |
| 2026-07-06 | Xu Zhenyu· Chief Scientific Officer | Sale | 7,393 | $5.17 | $38,241.77 | filing |
| 2026-07-06 | Menu Philippe· Chief Medical Officer | Sale | 7,393 | $5.16 | $38,156.01 | filing |
| 2026-07-06 | Verma Abhimanyu· Chief Technology Officer | Sale | 5,285 | $5.10 | $26,957.20 | filing |
| 2026-07-06 | Valente Manuela· Chief People Officer | Sale | 4,241 | $5.05 | $21,429.77 | filing |
| 2026-07-06 | CARDOZA GEORGE· Chief Financial Officer | Sale | 1,592 | $5.29 | $8,419.45 | filing |
| 2026-07-06 | Puylaert Kevin· Chief Sales Officer | Sale | 138 | $5.03 | $693.46 | filing |
| 2026-07-06 | Puylaert Kevin· Chief Sales Officer | Sale | 47 | $5.03 | $236.18 | filing |
| 2026-07-06 | Puylaert Kevin· Chief Sales Officer | Sale | 31 | $5.09 | $157.67 | filing |
| 2026-06-30 | Camblong Jurgi· Executive Chairman | Sale | 45,419 | $6.14 | $279,049.79 | filing |
| 2026-06-30 | Camblong Jurgi· Executive Chairman | Option exercise | 45,419 | $3.16 | $143,524.04 | filing |
| 2026-06-30 | Camblong Jurgi· Executive Chairman | Sale | 19,650 | $6.02 | $118,322.48 | filing |
| 2026-06-30 | Camblong Jurgi· Executive Chairman | Sale | 200 | $6.30 | $1,260.00 | filing |
| 2026-06-29 | Camblong Jurgi· Executive Chairman | Sale | 18,060 | $5.87 | $105,958.02 | filing |
| 2026-06-29 | Camblong Jurgi· Executive Chairman | Option exercise | 18,060 | $3.16 | $57,069.60 | filing |
| 2026-06-29 | Camblong Jurgi· Executive Chairman | Sale | 350 | $6.00 | $2,100.00 | filing |
| 2026-06-26 | Camblong Jurgi· Chief Executive Officer | Sale | 31,940 | $5.84 | $186,395.45 | filing |
| 2026-06-26 | Camblong Jurgi· Chief Executive Officer | Sale | 18,129 | $5.73 | $103,933.56 | filing |
| 2026-06-26 | Camblong Jurgi· Chief Executive Officer | Option exercise | 31,940 | $3.16 | $100,930.40 | filing |
| 2026-06-25 | Verma Abhimanyu· Chief Technology Officer | Sale | 6,944 | $5.51 | $38,229.50 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.